Notice Pursuant to the National Cooper, Ative Research and Production Act of 1993-Vehicle To Infrastructure Consortium, 35546 [2017-16050]

Download as PDF 35546 Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices personal identifying information in your comment, you should be aware that your entire comment, including your personal identifying information, may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Authority: The authorities for this action are the Surface Mining Control and Reclamation Act of 1977, as amended (30 U.S.C. 1201 et seq.), and the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). Dated: June 15, 2017. John A. Trelease, Acting Chief, Division of Regulatory Support. [FR Doc. 2017–16044 Filed 7–28–17; 8:45 am] BILLING CODE 4310–05–P DEPARTMENT OF JUSTICE filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Chrysler Group, LLC, Auburn Hills, MI, and Mercedes-Benz Research & Development North America, Inc., Sunnyvale, CA, have withdrawn as a parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and V2I Consortium intends to file additional written notifications disclosing all changes in membership. On December 3, 2014, V2I Consortium filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on December 31, 2014 (79 FR 78908). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. Antitrust Division Notice Pursuant to the National Cooper, Ative Research and Production Act of 1993—Vehicle To Infrastructure Consortium [FR Doc. 2017–16050 Filed 7–28–17; 8:45 am] BILLING CODE P Notice is hereby given that, on June 29, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Vehicle to Infrastructure Consortium (‘‘V2I Consortium’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Isosciences, LLC ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before September 29, 2017. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on May 17, 2017, Isosciences, LLC, 1017 West 9th Avenue, Building 10, Suite B, King of Prussia, Pennsylvania 19406 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Drug code sradovich on DSKBCFCHB2PROD with NOTICES Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. Lysergic acid diethylamide .............................................................................................................................................. 3,4-Methylenedioxyamphetamine .................................................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... Amphetamine ................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... Codeine ........................................................................................................................................................................... Morphine .......................................................................................................................................................................... The company plans to manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to their customers. Dated: July 24, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–16060 Filed 7–28–17; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 17:38 Jul 28, 2017 Jkt 241001 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: R & D Systems, Inc. ACTION: Notice of application. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 I I I I I II II II II comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 ADDRESSES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written DATES: 1235 1237 7315 7400 7404 1100 1105 9050 9300 Schedule E:\FR\FM\31JYN1.SGM 31JYN1

Agencies

[Federal Register Volume 82, Number 145 (Monday, July 31, 2017)]
[Notices]
[Page 35546]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16050]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooper, Ative Research and 
Production Act of 1993--Vehicle To Infrastructure Consortium

    Notice is hereby given that, on June 29, 2017, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Vehicle to Infrastructure 
Consortium (``V2I Consortium'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Chrysler Group, LLC, Auburn Hills, MI, and 
Mercedes-Benz Research & Development North America, Inc., Sunnyvale, 
CA, have withdrawn as a parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and V2I Consortium intends to file 
additional written notifications disclosing all changes in membership.
    On December 3, 2014, V2I Consortium filed its original notification 
pursuant to Section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to Section 6(b) of 
the Act on December 31, 2014 (79 FR 78908).

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-16050 Filed 7-28-17; 8:45 am]
 BILLING CODE P